Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN
PLAQRAN
1 other identifier
observational
230
1 country
1
Brief Summary
Sub arachnoid hemorrhage consecutive to intracranial aneurysm rupture is a devastating disease. Predictors of intracranial aneurysm rupture are limited and focus mainly on size and location. Platelet activation may have a deleterious role on aneurysm rupture. The assumption is that patients with ruptured intracranial aneurysm will present a higher rate of platelet activation compared to patients with non ruptured aneurysms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2017
CompletedFirst Submitted
Initial submission to the registry
January 17, 2018
CompletedFirst Posted
Study publicly available on registry
January 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 23, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 23, 2033
January 20, 2026
January 1, 2026
14.5 years
January 17, 2018
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients with platelet activation
comparison of this proportion between patients with ruptured versus non ruptured intracranial aneurysm
in the 7 days before embolisation
Interventions
In case of an endovascular treatment : * A blood sample (venous or arterial) of 10 ml will be taken at the beginning of the procedure, an intra aneurysmal blood sample (1mL) will be taken during the procedure and a blood sample (arterial) of 1 mL will be taken at the end of the procedure. * Iterative blood samples (arterial) of 10 mL will be taken at each follow up visit. In case of a surgery treatment : * A blood sample (venous or arterial) of 10 ml will be taken at the beginning of the surgery. * A Tissue sample will be taken during the surgery * Iterative blood samples (arterial) of 10 mL will be taken at each follow up visit.
Eligibility Criteria
Adult patients presenting a single or multiple intracranial aneurysm for which an intervention is planned (endovascular treatment or surgery)
You may qualify if:
- Patient aged 18 and over
- Patient presenting a single or multiple aneurysm
- Patient presenting an intracranial aneurysm for which an intervention is planned (endovascular treatment or surgery) : elective intervention for an unruptured aneurysm or emergency surgery for a broken aneurysm
You may not qualify if:
- Pregnant or breast feeding woman
- Patient benefiting from legal protection measures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondation Ophtalmologique A. de Rothschild
Paris, France, 75019, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2018
First Posted
January 24, 2018
Study Start
December 20, 2017
Primary Completion (Estimated)
June 23, 2032
Study Completion (Estimated)
June 23, 2033
Last Updated
January 20, 2026
Record last verified: 2026-01